104 related articles for article (PubMed ID: 23107489)
1. Catheter-based endomyocardial delivery of mesenchymal precursor cells using 3D echo guidance improves cardiac function in a chronic myocardial injury ovine model.
Cheng Y; Yi G; Conditt GB; Sheehy A; Kolodgie FD; Tellez A; Polyakov I; Gu A; Aboodi MS; Wallace-Bradley D; Schuster M; Martens T; Itescu S; Kaluza GL; Basu S; Virmani R; Granada JF; Sherman W
Cell Transplant; 2013; 22(12):2299-309. PubMed ID: 23107489
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function.
Houtgraaf JH; de Jong R; Kazemi K; de Groot D; van der Spoel TI; Arslan F; Hoefer I; Pasterkamp G; Itescu S; Zijlstra F; Geleijnse ML; Serruys PW; Duckers HJ
Circ Res; 2013 Jul; 113(2):153-66. PubMed ID: 23658436
[TBL] [Abstract][Full Text] [Related]
3. Injection of composite with bone marrow-derived mesenchymal stem cells and a novel synthetic hydrogel after myocardial infarction: a protective role in left ventricle function.
Chen J; Guo R; Zhou Q; Wang T
Kaohsiung J Med Sci; 2014 Apr; 30(4):173-80. PubMed ID: 24656157
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage.
Hamamoto H; Gorman JH; Ryan LP; Hinmon R; Martens TP; Schuster MD; Plappert T; Kiupel M; St John-Sutton MG; Itescu S; Gorman RC
Ann Thorac Surg; 2009 Mar; 87(3):794-801. PubMed ID: 19231391
[TBL] [Abstract][Full Text] [Related]
5. Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats.
Dai W; Hale SL; Kloner RA
Regen Med; 2007 Jan; 2(1):63-8. PubMed ID: 17465776
[TBL] [Abstract][Full Text] [Related]
6. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction.
Hashemi SM; Ghods S; Kolodgie FD; Parcham-Azad K; Keane M; Hamamdzic D; Young R; Rippy MK; Virmani R; Litt H; Wilensky RL
Eur Heart J; 2008 Jan; 29(2):251-9. PubMed ID: 18073226
[TBL] [Abstract][Full Text] [Related]
7. Long-acting beneficial effect of percutaneously intramyocardially delivered secretome of apoptotic peripheral blood cells on porcine chronic ischemic left ventricular dysfunction.
Pavo N; Zimmermann M; Pils D; Mildner M; Petrási Z; Petneházy Ö; Fuzik J; Jakab A; Gabriel C; Sipos W; Maurer G; Gyöngyösi M; Ankersmit HJ
Biomaterials; 2014 Apr; 35(11):3541-50. PubMed ID: 24439416
[TBL] [Abstract][Full Text] [Related]
8. Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation.
Feygin J; Mansoor A; Eckman P; Swingen C; Zhang J
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1772-80. PubMed ID: 17573463
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary Administration of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction.
Bobi J; Solanes N; Fernández-Jiménez R; Galán-Arriola C; Dantas AP; Fernández-Friera L; Gálvez-Montón C; Rigol-Monzó E; Agüero J; Ramírez J; Roqué M; Bayés-Genís A; Sánchez-González J; García-Álvarez A; Sabaté M; Roura S; Ibáñez B; Rigol M
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28468789
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function.
Suuronen EJ; Price J; Veinot JP; Ascah K; Kapila V; Guo XW; Wong S; Mesana TG; Ruel M
J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1249-58. PubMed ID: 17976457
[TBL] [Abstract][Full Text] [Related]
11. Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction.
Richardson JD; Psaltis PJ; Frost L; Paton S; Carbone A; Bertaso AG; Nelson AJ; Wong DT; Worthley MI; Gronthos S; Zannettino AC; Worthley SG
Cytotherapy; 2014 Apr; 16(4):460-70. PubMed ID: 24113430
[TBL] [Abstract][Full Text] [Related]
12. Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction.
de Jong R; van Hout GP; Houtgraaf JH; Kazemi K; Wallrapp C; Lewis A; Pasterkamp G; Hoefer IE; Duckers HJ
Circ Cardiovasc Interv; 2014 Oct; 7(5):673-83. PubMed ID: 25294400
[TBL] [Abstract][Full Text] [Related]
13. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties.
Price MJ; Chou CC; Frantzen M; Miyamoto T; Kar S; Lee S; Shah PK; Martin BJ; Lill M; Forrester JS; Chen PS; Makkar RR
Int J Cardiol; 2006 Aug; 111(2):231-9. PubMed ID: 16246440
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart.
Tao B; Cui M; Wang C; Ma S; Wu F; Yi F; Qin X; Liu J; Wang H; Wang Z; Ma X; Tian J; Chen Y; Wang J; Cao F
Theranostics; 2015; 5(2):196-205. PubMed ID: 25553108
[TBL] [Abstract][Full Text] [Related]
15. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous adventitial delivery of allogeneic bone marrow-derived stem cells via infarct-related artery improves long-term ventricular function in acute myocardial infarction.
Medicetty S; Wiktor D; Lehman N; Raber A; Popovic ZB; Deans R; Ting AE; Penn MS
Cell Transplant; 2012; 21(6):1109-20. PubMed ID: 22004910
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-mediated microbubble destruction enhances the efficacy of bone marrow mesenchymal stem cell transplantation and cardiac function.
Song X; Zhu H; Jin L; Wang J; Yang Q; Jin P; Li X
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):267-71. PubMed ID: 18785979
[TBL] [Abstract][Full Text] [Related]
18. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction.
Wang X; Zhen L; Miao H; Sun Q; Yang Y; Que B; Lopes Lao EP; Wu X; Ren H; Shi S; Lau WB; Ma X; Ma C; Nie S
Theranostics; 2015; 5(9):995-1006. PubMed ID: 26155315
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of cardiopoietic stem cells in the treatment of post-infarction left-ventricular dysfunction - From cardioprotection to functional repair in a translational pig infarction model.
Emmert MY; Wolint P; Jakab A; Sheehy SP; Pasqualini FS; Nguyen TDL; Hilbe M; Seifert B; Weber B; Brokopp CE; Macejovska D; Caliskan E; von Eckardstein A; Schwartlander R; Vogel V; Falk V; Parker KK; Gyöngyösi M; Hoerstrup SP
Biomaterials; 2017 Apr; 122():48-62. PubMed ID: 28107664
[TBL] [Abstract][Full Text] [Related]
20. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.
Zeng L; Hu Q; Wang X; Mansoor A; Lee J; Feygin J; Zhang G; Suntharalingam P; Boozer S; Mhashilkar A; Panetta CJ; Swingen C; Deans R; From AH; Bache RJ; Verfaillie CM; Zhang J
Circulation; 2007 Apr; 115(14):1866-75. PubMed ID: 17389266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
